The Board of Directors of Krishna Institute of Medical Sciences Limited convened a meeting on May 15, 2026, commencing at 2:00 PM and concluding at 5:00 PM, during which it approved a series of key organizational appointments and a board-level re-designation. The disclosures were made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment of Cost Auditors

The board approved the appointment of M/s. Sagar & Associates, Cost Accountants, as the Cost Auditors of the company for the financial year 2026-27. The firm has been engaged to conduct the audit of the cost records of the company for the term April 1, 2026 to March 31, 2027, with the appointment effective May 15, 2026.

M/s. Sagar & Associates is described as a leading firm of Cost & Management Accountants with diversified activities in the Cost and Management Accounting area. The firm comprises qualified Cost Accountants and has undertaken assignments across various industries, serving leading companies with multiple locations and diversified product portfolios. The firm also has significant exposure to ERP systems, including SAP and ORACLE.

Senior Management Personnel Appointments

Based on the recommendation of the Nomination and Remuneration Committee at its meeting held on May 15, 2026, the board identified the following officials as Senior Management Personnel of the company with immediate effect:

Profiles of Newly Appointed Senior Management Personnel

Mr. Sachin Ashok Salvi – Chief Finance Officer

Mr. Salvi is a Chartered Accountant with over 21 years of experience in finance, accounting, financial reporting, and regulatory compliance. He has played a key role in managing IPO processes, including financial restatements and due diligence. His expertise spans IndAS, ICDS, ICDR regulations, GST, direct and indirect taxation, and regulatory liaison with SEBI, RBI, and tax authorities. He began his career with SD Khanolkar & Co., Mumbai, and later served as Finance Controller and CFO at Thyrocare Group, Navi Mumbai.

Mrs. Nagajayanthi J.R – Company Secretary & Compliance Officer

Mrs. Nagajayanthi J.R is a Fellow Member of the Institute of Company Secretaries of India. She holds a B.A. (Honours) in Economics from Delhi University, a Law degree from Osmania University, and has completed both a Master's degree and a Doctorate in Financial Management. She brings over 25 years of experience in the fields of Secretarial practice, Legal affairs, Corporate Finance, and Compliance.

Mr. Bhaskar Reddy R.K – Chief Risk Officer & Chief Internal Audit

Mr. Bhaskar Reddy R.K is a Chartered Accountant with over 12 years of experience in managing internal audits, governance reviews, risk assessments, and control evaluations. He is skilled in identifying process inefficiencies, strengthening internal controls, improving governance frameworks, and delivering actionable recommendations to management for operational and risk optimization. His experience includes 3 years with global consulting firms — Deloitte and BDO — in Risk Advisory and Business Restructuring engagements.

Re-designation of Mr. Adwik Bollineni

The board also approved the re-designation of Mr. Adwik Bollineni from Non-Executive & Non-Independent Director to Executive & Non-Independent Director of the company, effective May 15, 2026. Mr. Bollineni is a governing member of the Aditya Educational Society and has transformed Srikakulam's Great Eastern Medical School (GEMS) into Andhra Pradesh's second most sought-after medical college. Under his leadership, GEMS became the first and only Indian institution accredited by the Royal College of Surgeons of England for surgical excellence, and GEMS earned the 2024 Chief Minister's Award as the best hospital in Andhra Pradesh. Mr. Adwik Bollineni is the son of Dr. B. Bhaskara Rao, CMD, and brother of Dr. Abhinay Bollineni, Director & CEO.

Regulatory Disclosure

All disclosures pertaining to these appointments and re-designation have been made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January 2026. The relevant information has also been uploaded on the company's website at kimshospitals.com under the Disclosures section.

Krishna Institute of Medical Sciences Limited has announced a conference call for analysts and investors, scheduled for Monday, May 18, 2026, at 9:30 am IST. The call, hosted by IIFL Capital, will focus on the company's business strategy and outlook following the declaration of its Q4FY26 financial results. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Details

The earnings conference call will bring together key members of the company's senior leadership to engage with the investment community. The following table summarises the key details of the event:

Management Participants

The conference call will feature participation from the following senior executives of Krishna Institute of Medical Sciences:

• Dr. Bhaskara Rao Bollineni – Founder & Managing Director
• Dr. Abhinay Bollineni – Executive Director & CEO
• Mr. Sachin Salvi – Chief Financial Officer

Regulatory Disclosure

The intimation was filed by Nagajayanthi J R, Company Secretary & Compliance Officer of Krishna Institute of Medical Sciences Limited, on May 12, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The conference call is accessible to international participants across multiple time zones, with the event corresponding to 12:00 pm in Hong Kong and Singapore, 5:00 am in the UK, and 12:00 am ET in the USA.